EA199700449A1 - METHOD OF PREVENTION OF OSTEOPOROSIS - Google Patents

METHOD OF PREVENTION OF OSTEOPOROSIS

Info

Publication number
EA199700449A1
EA199700449A1 EA199700449A EA199700449A EA199700449A1 EA 199700449 A1 EA199700449 A1 EA 199700449A1 EA 199700449 A EA199700449 A EA 199700449A EA 199700449 A EA199700449 A EA 199700449A EA 199700449 A1 EA199700449 A1 EA 199700449A1
Authority
EA
Eurasian Patent Office
Prior art keywords
osteoporosis
prevention
aminodiphosphate
alendronate
women
Prior art date
Application number
EA199700449A
Other languages
Russian (ru)
Other versions
EA000677B1 (en
Inventor
Эшли Дж. Йэтс
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199700449A1 publication Critical patent/EA199700449A1/en
Publication of EA000677B1 publication Critical patent/EA000677B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Алендронат, аминодифосфат, может предотвращать остеопороз у женщин в ранней постменопаузе.Международная заявка была опубликована вместе с отчетом о международном поиске.Alendronate, aminodiphosphate, can prevent osteoporosis in women in early postmenopause. The international application was published along with an international search report.

EA199700449A 1995-06-02 1996-05-29 Method for preventing of osteoporosis EA000677B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
EA199700449A1 true EA199700449A1 (en) 1998-06-25
EA000677B1 EA000677B1 (en) 2000-02-28

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700449A EA000677B1 (en) 1995-06-02 1996-05-29 Method for preventing of osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527L (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
BR0209360A (en) * 2001-05-02 2004-06-08 Novartis Ag Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis.
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
IS4617A (en) 1997-11-19
BR9609020A (en) 1999-07-06
NO975527D0 (en) 1997-12-01
TR199701482T1 (en) 1998-03-21
SK159597A3 (en) 1998-06-03
EP0828496A1 (en) 1998-03-18
NO975527L (en) 1997-12-01
CA2222318A1 (en) 1996-12-05
BG63103B1 (en) 2001-04-30
HUP9900659A2 (en) 2001-04-28
CN1192685A (en) 1998-09-09
PL323669A1 (en) 1998-04-14
NZ308935A (en) 2000-07-28
EE03306B1 (en) 2000-12-15
AU5882496A (en) 1996-12-18
ZA964465B (en) 1996-12-11
KR19990022436A (en) 1999-03-25
IL118422A0 (en) 1996-09-12
CZ381197A3 (en) 1998-06-17
AU709196B2 (en) 1999-08-26
EA000677B1 (en) 2000-02-28
WO1996038156A1 (en) 1996-12-05
HUP9900659A3 (en) 2002-12-28
JPH10506648A (en) 1998-06-30
BG102060A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
HN1996000017A (en) ISOTIAZOLONES
IT1285134B1 (en) ALTERNATIVE COMPRESSOR.
EA200000381A1 (en) PREPARATION OF 2-METHYL-TIENO-BENZODIAZEPINA
ES2180899T3 (en) OLANZAPINE DIHYDRATE.
DE69621079D1 (en) turbomachinery
DE69525369T2 (en) CONTINUOUS POLYMERIZATION PROCESS OF POLYAMIDES
MA23778A1 (en) PURINE-6-ONES-2.9 DISUBSTITUTED
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
IT1289709B1 (en) HERMETIC ALTERNATIVE COMPRESSOR.
ES2140853T3 (en) DEOXYGENATION OF AN OILY PRODUCT WITH A LACCASE.
DE69614326D1 (en) LOW LEAKAGE MOSFET
ES2186807T3 (en) THROMBIN INHIBITORS.
EA199700449A1 (en) METHOD OF PREVENTION OF OSTEOPOROSIS
TR199900430T2 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta$b]benzofurans.
EA199800029A1 (en) METHOD OF OBTAINING BENZO [b] TIOPHENES
EA199800028A1 (en) VINYLSULPHOXIDES AND METHODS OF THEIR SYNTHESIS
TR199801087T2 (en) 4,10 �-diasetoxy-2alpha-Benzoyloxy-5 �, 20 epoxy-1-hydroxy-9-oxo-19-norsiclopropa (G) tax-11-en-13alpha-yl
ITTO920528A1 (en) FOOTWEAR BACKGROUND.
FR2704421B1 (en) Ligament prosthesis.
NL1003205A1 (en) Sports facility.
UA43389C2 (en) METHOD OF REDUCING SERUM CALCIUM LEVELS
ES1032948Y (en) APPLY.
FR2656141B1 (en) PUBLIC ADVERTISER.
ES1028951Y (en) CYBER SOURCE.
NO954451D0 (en) Underwear, as well as insole

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU